Adma Biologics Stock Forecast

Buy candidate since Jul 02, 2026

The ADMA Biologics Inc stock price gained 3.95% on the last trading day (Thursday, 2nd Jul 2026), rising from $8.61 to $8.95. During the last trading day the stock fluctuated 4.04% from a day low at $8.66 to a day high of $9.01. The price has risen in 7 of the last 10 days and is up by 6.29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $38.68 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $9.22 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -22.34% during the next 3 months and, with a 90% probability hold a price between $5.19 and $7.16 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ADMA Signals & Forecast

Mostly positive signals in the chart today. The ADMA Biologics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.64 and $8.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 17.76%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for ADMA Biologics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.50 and $8.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ADMA Biologics Inc finds support just below today's level at $8.50. If this is broken, then the next support from accumulated volume will be at $8.47 and $8.17.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.350 between high and low, or 4.04%. For the last week, the stock has had daily average volatility of 4.05%.

Our recommended stop-loss: $8.47 (-5.34%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 21 days ago.)

Trading Expectations (ADMA) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect ADMA Biologics Inc to open at $8.87, and during the day (based on 14 day Average True Range), to move between $8.76 and $9.14, which gives a possible trading interval of +/-$0.374 (+/-4.27%) up or down from last closing price. If ADMA Biologics Inc takes out the full calculated possible swing range there will be an estimated 4.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.50 (5.03%) than the resistance at $10.08 (12.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ADMA Biologics Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.784 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $8.87 ( 0.86%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk